Annual Operating Expenses
$1.36 B
+$31.59 M+2.38%
31 December 2023
Summary:
Sarepta Therapeutics annual total operating expenses is currently $1.36 billion, with the most recent change of +$31.59 million (+2.38%) on 31 December 2023. During the last 3 years, it has risen by +$319.94 million (+30.74%). SRPT annual operating expenses is now at all-time high.SRPT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$353.29 M
+$34.20 M+10.72%
30 September 2024
Summary:
Sarepta Therapeutics quarterly total operating expenses is currently $353.29 million, with the most recent change of +$34.20 million (+10.72%) on 30 September 2024. Over the past year, it has increased by +$37.65 million (+11.93%). SRPT quarterly operating expenses is now -13.16% below its all-time high of $406.82 million, reached on 30 June 2022.SRPT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.4% | +11.9% |
| 3 y3 years | +30.7% | +76.3% |
| 5 y5 years | +122.9% | +68.6% |
SRPT Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +30.7% | -13.2% | +76.3% |
| 5 y | 5 years | at high | +122.9% | -13.2% | +76.3% |
| alltime | all time | at high | >+9999.0% | -13.2% | >+9999.0% |
Sarepta Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $353.29 M(+10.7%) |
| June 2024 | - | $319.09 M(-2.7%) |
| Mar 2024 | - | $328.00 M(+0.0%) |
| Dec 2023 | $1.36 B(+2.4%) | $327.98 M(+3.9%) |
| Sept 2023 | - | $315.63 M(-12.5%) |
| June 2023 | - | $360.63 M(+1.1%) |
| Mar 2023 | - | $356.57 M(+6.6%) |
| Dec 2022 | $1.33 B(+26.0%) | $334.46 M(+4.0%) |
| Sept 2022 | - | $321.67 M(-20.9%) |
| June 2022 | - | $406.82 M(+52.8%) |
| Mar 2022 | - | $266.27 M(-3.4%) |
| Dec 2021 | $1.05 B(+1.3%) | $275.53 M(+37.5%) |
| Sept 2021 | - | $200.42 M(-35.8%) |
| June 2021 | - | $312.15 M(+17.2%) |
| Mar 2021 | - | $266.45 M(-9.2%) |
| Dec 2020 | $1.04 B(+23.0%) | $293.45 M(+10.3%) |
| Sept 2020 | - | $265.98 M(+1.4%) |
| June 2020 | - | $262.38 M(+19.8%) |
| Mar 2020 | - | $219.08 M(-28.1%) |
| Dec 2019 | $846.57 M(+38.7%) | $304.76 M(+45.4%) |
| Sept 2019 | - | $209.59 M(+15.9%) |
| June 2019 | - | $180.88 M(+19.5%) |
| Mar 2019 | - | $151.34 M(-27.4%) |
| Dec 2018 | $610.47 M(+110.2%) | $208.42 M(+49.0%) |
| Sept 2018 | - | $139.84 M(-18.9%) |
| June 2018 | - | $172.44 M(+92.1%) |
| Mar 2018 | - | $89.76 M(+13.0%) |
| Dec 2017 | $290.44 M(+7.8%) | $79.47 M(+25.7%) |
| Sept 2017 | - | $63.20 M(-31.7%) |
| June 2017 | - | $92.58 M(+67.2%) |
| Mar 2017 | - | $55.36 M(-39.7%) |
| Dec 2016 | $269.50 M(+21.7%) | $91.81 M(+62.4%) |
| Sept 2016 | - | $56.53 M(-8.8%) |
| June 2016 | - | $61.98 M(+3.8%) |
| Mar 2016 | - | $59.70 M(-9.1%) |
| Dec 2015 | $221.44 M(+54.3%) | $65.70 M(+26.9%) |
| Sept 2015 | - | $51.76 M(+22.9%) |
| June 2015 | - | $42.11 M(-31.9%) |
| Mar 2015 | - | $61.86 M(+38.2%) |
| Dec 2014 | $143.55 M(+37.4%) | $44.75 M(+28.8%) |
| Sept 2014 | - | $34.73 M(+5.7%) |
| June 2014 | - | $32.85 M(+5.3%) |
| Mar 2014 | - | $31.21 M(-12.0%) |
| Dec 2013 | $104.50 M(+55.9%) | $35.48 M(+21.9%) |
| Sept 2013 | - | $29.10 M(+45.2%) |
| June 2013 | - | $20.04 M(+0.7%) |
| Mar 2013 | - | $19.89 M(+12.3%) |
| Dec 2012 | $67.03 M(-19.2%) | $17.70 M(+22.3%) |
| Sept 2012 | - | $14.48 M(-13.6%) |
| June 2012 | - | $16.76 M(-7.3%) |
| Mar 2012 | - | $18.09 M(-19.9%) |
| Dec 2011 | $82.92 M(+64.7%) | $22.59 M(+20.2%) |
| Sept 2011 | - | $18.80 M(-13.4%) |
| June 2011 | - | $21.71 M(+9.5%) |
| Mar 2011 | - | $19.83 M(+14.9%) |
| Dec 2010 | $50.35 M | $17.26 M(+38.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $12.50 M(+7.2%) |
| June 2010 | - | $11.66 M(+30.5%) |
| Mar 2010 | - | $8.94 M(-1.7%) |
| Dec 2009 | $33.09 M(-14.7%) | $9.10 M(-1.9%) |
| Sept 2009 | - | $9.27 M(+15.8%) |
| June 2009 | - | $8.01 M(+19.3%) |
| Mar 2009 | - | $6.71 M(-19.8%) |
| Dec 2008 | $38.80 M(-12.0%) | $8.37 M(-24.6%) |
| Sept 2008 | - | $11.11 M(+12.6%) |
| June 2008 | - | $9.86 M(+4.3%) |
| Mar 2008 | - | $9.46 M(-12.9%) |
| Dec 2007 | $44.09 M(+33.2%) | $10.85 M(-5.0%) |
| Sept 2007 | - | $11.43 M(+2.1%) |
| June 2007 | - | $11.19 M(+5.4%) |
| Mar 2007 | - | $10.62 M(+20.8%) |
| Dec 2006 | $33.10 M(+48.4%) | $8.79 M(+20.6%) |
| Sept 2006 | - | $7.29 M(-2.0%) |
| June 2006 | - | $7.44 M(-22.4%) |
| Mar 2006 | - | $9.59 M(+51.6%) |
| Dec 2005 | $22.30 M(-12.5%) | $6.32 M(+21.6%) |
| Sept 2005 | - | $5.20 M(+0.2%) |
| June 2005 | - | $5.19 M(-7.2%) |
| Mar 2005 | - | $5.59 M(+7.0%) |
| Dec 2004 | $25.47 M(+28.4%) | $5.22 M(+1.8%) |
| Sept 2004 | - | $5.13 M(-29.4%) |
| June 2004 | - | $7.27 M(-7.4%) |
| Mar 2004 | - | $7.85 M(+7.7%) |
| Dec 2003 | $19.84 M(-24.2%) | $7.29 M(+43.2%) |
| Sept 2003 | - | $5.09 M(+37.1%) |
| June 2003 | - | $3.72 M(-0.6%) |
| Mar 2003 | - | $3.74 M(-13.5%) |
| Dec 2002 | $26.18 M(+62.5%) | $4.32 M(-22.9%) |
| Sept 2002 | - | $5.60 M(-31.0%) |
| June 2002 | - | $8.12 M(-0.2%) |
| Mar 2002 | - | $8.13 M(+61.8%) |
| Dec 2001 | $16.11 M(+34.7%) | $5.03 M(+37.6%) |
| Sept 2001 | - | $3.65 M(-5.7%) |
| June 2001 | - | $3.87 M(+8.9%) |
| Mar 2001 | - | $3.56 M(-2.8%) |
| Dec 2000 | $11.96 M(+37.4%) | $3.66 M(+30.7%) |
| Sept 2000 | - | $2.80 M(-8.2%) |
| June 2000 | - | $3.05 M(+24.7%) |
| Mar 2000 | - | $2.45 M(-2.2%) |
| Dec 1999 | $8.70 M(+7.4%) | $2.50 M(+8.7%) |
| Sept 1999 | - | $2.30 M(+15.0%) |
| June 1999 | - | $2.00 M(+11.1%) |
| Mar 1999 | - | $1.80 M(-30.8%) |
| Dec 1998 | $8.10 M(+80.0%) | $2.60 M(+30.0%) |
| Sept 1998 | - | $2.00 M(+5.3%) |
| June 1998 | - | $1.90 M(+11.8%) |
| Mar 1998 | - | $1.70 M(+41.7%) |
| Dec 1997 | $4.50 M(+60.7%) | $1.20 M(+20.0%) |
| Sept 1997 | - | $1.00 M(-33.3%) |
| June 1997 | - | $1.50 M(+87.5%) |
| Mar 1997 | - | $800.00 K |
| Dec 1996 | $2.80 M | - |
FAQ
- What is Sarepta Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual operating expenses year-on-year change?
- What is Sarepta Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly operating expenses year-on-year change?
What is Sarepta Therapeutics annual total operating expenses?
The current annual operating expenses of SRPT is $1.36 B
What is the all time high annual operating expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total operating expenses is $1.36 B
What is Sarepta Therapeutics annual operating expenses year-on-year change?
Over the past year, SRPT annual total operating expenses has changed by +$31.59 M (+2.38%)
What is Sarepta Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SRPT is $353.29 M
What is the all time high quarterly operating expenses for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total operating expenses is $406.82 M
What is Sarepta Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SRPT quarterly total operating expenses has changed by +$37.65 M (+11.93%)